OBJECTIVES: This study sought to describe the clinical correlates and heritability of the early repolarization pattern (ERP) in 2 large, population-based cohorts. BACKGROUND: There is growing recognition that ERP is associated with adverse outcomes. METHODS: Participants of the Framingham Heart Study (FHS) (N = 3,995) and the Health 2000 Survey (H2K) (N = 5,489) were included. ERP was defined as a J-point elevation ≥0.1 mV in ≥2 leads in either the inferior (II, III, aVF) or lateral (I, aVL, V(4-6)) territory or both. We tested the association between clinical characteristics and ERP, and estimated sibling recurrence risk. RESULTS: ERP was present in 243 of 3,955 (6.1%) of FHS and 180 of 5,489 (3.3%) of H2K subjects. Male sex, younger age, lower systolic blood pressure, higher Sokolow-Lyon index, and lower Cornell voltage were independently associated with the presence of ERP. In the FHS sample, siblings of individuals with ERP had an ERP prevalence of 11.6% (recurrence risk ratio of 1.89). Siblings of individuals with ERP had an increased unadjusted odds of ERP (odds ratio: 2.22, 95% confidence interval: 1.01 to 4.85, p = 0.047). CONCLUSIONS: ERP has strong association with clinical factors and has evidence for a heritable basis in the general population. Further assessment of the genetic determinants of ERP is warranted.
OBJECTIVES: This study sought to describe the clinical correlates and heritability of the early repolarization pattern (ERP) in 2 large, population-based cohorts. BACKGROUND: There is growing recognition that ERP is associated with adverse outcomes. METHODS:Participants of the Framingham Heart Study (FHS) (N = 3,995) and the Health 2000 Survey (H2K) (N = 5,489) were included. ERP was defined as a J-point elevation ≥0.1 mV in ≥2 leads in either the inferior (II, III, aVF) or lateral (I, aVL, V(4-6)) territory or both. We tested the association between clinical characteristics and ERP, and estimated sibling recurrence risk. RESULTS: ERP was present in 243 of 3,955 (6.1%) of FHS and 180 of 5,489 (3.3%) of H2K subjects. Male sex, younger age, lower systolic blood pressure, higher Sokolow-Lyon index, and lower Cornell voltage were independently associated with the presence of ERP. In the FHS sample, siblings of individuals with ERP had an ERP prevalence of 11.6% (recurrence risk ratio of 1.89). Siblings of individuals with ERP had an increased unadjusted odds of ERP (odds ratio: 2.22, 95% confidence interval: 1.01 to 4.85, p = 0.047). CONCLUSIONS: ERP has strong association with clinical factors and has evidence for a heritable basis in the general population. Further assessment of the genetic determinants of ERP is warranted.
Authors: W H Linda Kao; Dan E Arking; Wendy Post; Thomas D Rea; Nona Sotoodehnia; Ronald J Prineas; Bryan Bishe; Betty Q Doan; Eric Boerwinkle; Bruce M Psaty; Gordon F Tomaselli; Josef Coresh; David S Siscovick; Eduardo Marbán; Peter M Spooner; Gregory L Burke; Aravinda Chakravarti Journal: Circulation Date: 2009-02-09 Impact factor: 29.690
Authors: Jani T Tikkanen; Olli Anttonen; M Juhani Junttila; Aapo L Aro; Tuomas Kerola; Harri A Rissanen; Antti Reunanen; Heikki V Huikuri Journal: N Engl J Med Date: 2009-11-16 Impact factor: 91.245
Authors: Elena Burashnikov; Ryan Pfeiffer; Héctor Barajas-Martinez; Eva Delpón; Dan Hu; Mayurika Desai; Martin Borggrefe; Michel Häissaguerre; Ronald Kanter; Guido D Pollevick; Alejandra Guerchicoff; Ruben Laiño; Mark Marieb; Koonlawee Nademanee; Gi-Byoung Nam; Roberto Robles; Rainer Schimpf; Dwight D Stapleton; Sami Viskin; Stephen Winters; Christian Wolpert; Samuel Zimmern; Christian Veltmann; Charles Antzelevitch Journal: Heart Rhythm Date: 2010-10-14 Impact factor: 6.343
Authors: Arthur L Klatsky; Rudolph Oehm; Robert A Cooper; Natalia Udaltsova; Mary Anne Armstrong Journal: Am J Med Date: 2003-08-15 Impact factor: 4.965
Authors: Moritz F Sinner; Wibke Reinhard; Martina Müller; Britt-Maria Beckmann; Eimo Martens; Siegfried Perz; Arne Pfeufer; Janina Winogradow; Klaus Stark; Christa Meisinger; H-Erich Wichmann; Annette Peters; Günter A J Riegger; Gerhard Steinbeck; Christian Hengstenberg; Stefan Kääb Journal: PLoS Med Date: 2010-07-27 Impact factor: 11.069
Authors: Michel Haïssaguerre; Stéphanie Chatel; Frederic Sacher; Rukshen Weerasooriya; Vincent Probst; Gildas Loussouarn; Marc Horlitz; Ruedige Liersch; Eric Schulze-Bahr; Arthur Wilde; Stefan Kääb; Joseph Koster; Yoram Rudy; Hervé Le Marec; Jean Jacques Schott Journal: J Cardiovasc Electrophysiol Date: 2009-01
Authors: Varsha Keelara Tanguturi; Peter A Noseworthy; Christopher Newton-Cheh; Aaron L Baggish Journal: Sports Med Date: 2012-05-01 Impact factor: 11.136
Authors: Tuomas Kenttä; Kimmo Porthan; Jani T Tikkanen; Heikki Väänänen; Lasse Oikarinen; Matti Viitasalo; Hannu Karanko; Maarit Laaksonen; Heikki V Huikuri Journal: Ann Noninvasive Electrocardiol Date: 2014-11-04 Impact factor: 1.468
Authors: Ulric Vinsonneau; Vanida Pangnarind-Heinz; Nicolas Paleiron; Louis Marie Heinz; Guenole Rohel; Marie Piquemal; Philippe Castellant; Jerome Abalea; Jacques Mansourati; Philippe Paule Journal: Ann Noninvasive Electrocardiol Date: 2014-11-13 Impact factor: 1.468
Authors: Dan Hu; Hector Barajas-Martínez; Andre Terzic; Sungjo Park; Ryan Pfeiffer; Elena Burashnikov; Yuesheng Wu; Martin Borggrefe; Christian Veltmann; Rainer Schimpf; John J Cai; Gi-Byong Nam; Pramod Deshmukh; Melvin Scheinman; Mark Preminger; Jonathan Steinberg; Angélica López-Izquierdo; Daniela Ponce-Balbuena; Christian Wolpert; Michel Haïssaguerre; José Antonio Sánchez-Chapula; Charles Antzelevitch Journal: Int J Cardiol Date: 2014-01-04 Impact factor: 4.164
Authors: Ulric Vinsonneau; Barbara Pinon; Nicolas Paleiron; Gwenole Rohel; Marie Piquemal; Catherine Desideri-Vaillant; Philippe Castellant; Jérome Abaléa; Valérie Valls-Bertaut; François Carré; Jacques Mansourati; Philippe Paule Journal: Ann Noninvasive Electrocardiol Date: 2013-06-09 Impact factor: 1.468
Authors: Joseph A Walsh; Leonard Ilkhanoff; Elsayed Z Soliman; Ronald Prineas; Kiang Liu; Hongyan Ning; Donald M Lloyd-Jones Journal: J Am Coll Cardiol Date: 2013-02-26 Impact factor: 24.094